PFBT
NUVB icon

Parkside Financial Bank & Trust’s Nuvation Bio NUVB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80
Closed -$717 – 2757
2025
Q4 		$717 Buy
+80
New +$496 ﹤0.01% 2461

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parkside Financial Bank & Trust's NUVB Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 80 shares — an estimated $717 sold.

Parkside Financial Bank & Trust first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $717 in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 80 Nuvation Bio shares in Q1 2026, an estimated $717.
  • Parkside Financial Bank & Trust first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's Nuvation Bio position peaked at $717 in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.